The biology of the HIV-1 latent reservoir and implications for cure strategies

LB Cohn, N Chomont, SG Deeks - Cell host & microbe, 2020 - cell.com
Antiretroviral therapy (ART) inhibits HIV replication but is not curative. During ART, the
integrated HIV genome persists indefinitely within CD4+ T cells and perhaps other cells …

HIV reservoirs as obstacles and opportunities for an HIV cure

TW Chun, S Moir, AS Fauci - Nature immunology, 2015 - nature.com
The persistence of HIV reservoirs remains a formidable obstacle to achieving sustained
virologic remission in HIV-infected individuals after antiretroviral therapy (ART) is …

B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers

Y Fukazawa, R Lum, AA Okoye, H Park, K Matsuda… - Nature medicine, 2015 - nature.com
Chronic-phase HIV and simian immunodeficiency virus (SIV) replication is reduced by as
much as 10,000-fold in elite controllers (ECs) compared with typical progressors (TPs), but …

TIGIT marks exhausted T cells, correlates with disease progression, and serves as a target for immune restoration in HIV and SIV infection

GM Chew, T Fujita, GM Webb, BJ Burwitz, HL Wu… - PLoS …, 2016 - journals.plos.org
HIV infection induces phenotypic and functional changes to CD8+ T cells defined by the
coordinated upregulation of a series of negative checkpoint receptors that eventually result …

Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size

V Jain, W Hartogensis, P Bacchetti… - The Journal of …, 2013 - academic.oup.com
Abstract Background. CD4+/CD8+ T-cell activation levels often remain elevated in chronic
human immunodeficiency virus (HIV) infection despite initiation of antiretroviral therapy …

Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient

SA Yukl, E Boritz, M Busch, C Bentsen, TW Chun… - PLoS …, 2013 - journals.plos.org
There is intense interest in developing curative interventions for HIV. How such a cure will
be quantified and defined is not known. We applied a series of measurements of HIV …

Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis

PY Hsue, PW Hunt, A Schnell, SC Kalapus, R Hoh… - Aids, 2009 - journals.lww.com
Objective: HIV-seropositive patients are at higher risk for atherosclerosis than HIV-
seronegative persons. This has been variably attributed to antiretroviral drug toxicity …

Cell-Based Measures of Viral Persistence Are Associated With Immune Activation and Programmed Cell Death Protein 1 (PD-1)–Expressing CD4+ T cells

H Hatano, V Jain, PW Hunt, TH Lee… - The Journal of …, 2013 - academic.oup.com
Background. Studies aimed at defining the association between host immune responses
and human immunodeficiency virus (HIV) persistence during therapy are necessary to …

Towards an HIV-1 cure: measuring the latent reservoir

KM Bruner, NN Hosmane, RF Siliciano - Trends in microbiology, 2015 - cell.com
The latent reservoir (LR) of HIV-1 in resting memory CD4+ T cells serves as a major barrier
to curing HIV-1 infection. While many PCR-and culture-based assays have been used to …

Perforin Expression Directly Ex Vivo by HIV-Specific CD8+ T-Cells Is a Correlate of HIV Elite Control

AR Hersperger, F Pereyra, M Nason, K Demers… - PLoS …, 2010 - journals.plos.org
Many immune correlates of CD8+ T-cell-mediated control of HIV replication, including
polyfunctionality, proliferative ability, and inhibitory receptor expression, have been …